Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity (Q39817453)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 13, 2010

Language	Label	Description	Also known as
English	Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity	scientific article published on November 13, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Xiran Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Huang Tian

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Meng Xianmin

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21075543

26 August 2024

publication date

13 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0306987710004470?httpAccept=text/xml

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

https://api.elsevier.com/content/article/PII:S0306987710004470?httpAccept=text/plain

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Medical Hypotheses

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

339-342

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Vitiligo update

1

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Psychologic effects of vitiligo: a critical incident analysis

2

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Update on skin repigmentation therapies in vitiligo

3

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff

5

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

6

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

8

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

B-lymphocyte contributions to human autoimmune disease

9

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Travelling with the BAFF/BLyS family: are we there yet?

10

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

T cell costimulation by the TNF ligand BAFF.

11

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Detection of Antibodies to Melanocytes in Vitiligo by Specific Immunoprecipitation

12

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo

13

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo

14

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo

15

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity

16

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

In Vivo Destruction of Melanocytes by the IgG Fraction of Serum from Patients with Vitiligo

17

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Apoptosis of melanocytes in vitiligo results from antibody penetration

18

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

19

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.

20

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1

21

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

An immunohistological study of cutaneous lymphocytes in vitiligo.

22

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site

23

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.

24

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Autoimmunity as an aetiological factor in vitiligo

25

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Peripheral blood lymphocyte imbalance in Koreans with active vitiligo

26

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Characterization of lymphocyte surface markers in patients with vitiligo

27

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

28

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Autoimmunity: increasing suspects in the CD4+ T cell lineup

29

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells

30

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

BAFF augments certain Th1-associated inflammatory responses.

31

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

32

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples

33

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo

34

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Serum concentration of the soluble interleukin-2 receptor in vitiligo patients

35

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo

36

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients

37

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity

38

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses

39

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice

40

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?

41

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Expression of AIRE in thymocytes and peripheral lymphocytes

42

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

AIRE regulates T-cell-independent B-cell responses through BAFF.

43

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

The autoimmune regulator gene (AIRE) is strongly associated with vitiligo

44

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Targeting of BAFF and APRIL for autoimmunity and oncology

45

1 reference

10.1016/J.MEHY.2010.10.034

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Identifiers

10.1016/J.MEHY.2010.10.034

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39817453&oldid=2236615009"